Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 390Unknown 145Terminated 99Recruiting 81Active not recruiting 50Not yet recruiting 34Withdrawn 25Suspended 5Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastases From Colorectal Cancer (mCRC) 1

Interventions

Drug Therapy 4Cisplatin 4Chemoradiotherapy 4lenvatinib 3camrelizumab 3Specimen Handling 3Paclitaxel 3Oxaliplatin 3Carboplatin 3toripalimab 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Patient Navigation 2Methods 2Leucovorin 2Laparoscopy 2Fluorouracil 2Fluorodeoxyglucose F18 2Educational Status 2Early Intervention, Educational 2Capecitabine 2Biopsy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tislelizumab 1sintilimab 1pembrolizumab 1nimotuzumab 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Irinotecan × Gastrointestinal × Clear all
NCT07441369 2026-04-27

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Fudan University

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Liver Metastases From Colorectal Cancer (mCRC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡